Three companies. One mission.
A seamless path from discovery to clinic
Integrated CMC Partnership - Accelerating drug development for innovators
Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions have come together to form an Integrated CMC Partnership—a unique collaboration offering innovator biopharma companies end-to-end Chemistry, Manufacturing & Controls (CMC) services.
By combining complementary strengths — Sai in API development, Agility in formulation sciences, and Centrix in drug product development and clinical manufacturing—we help innovators move efficiently from preclinical studies to first-in-human (FIH) trials and beyond.
Our partnership delivers a faster, more efficient, and more collaborative pathway for your drug candidates.
Key benefits include:
• Broad expertise across the CMC value chain, supported by state-of-the-art labs and manufacturing facilities
• End-to-end coverage: from synthetic route scouting to drug substance manufacturing, and from pre-formulation to clinical trial materials
• Cross-functional optimization that reduces duplication, risks, costs, and timelines
• Flexibility to proactively address emerging technical risks
• Seamless knowledge flow and sample transfer between technical teams
• Single point of contact from Day One for alignment and accountability.
Our Comprehensive CMC services
• API synthesis & scale-up
• API developability & modification strategies
• Bioenhancement approaches
• Pre-clinical & clinical formulation development
• Clinical API & drug product manufacturing
• IND-enabling packages – CTD ready
• Integrated analytical methods & stability studies
• Parallel API & drug product development
For more information, Contact Us
What our leaders say
“By bringing together our complementary strengths, we can deliver far greater value to innovators—helping them translate ideas into medicines with speed, quality, and efficiency.”
– Krishna Kanumuri, MD & CEO, Sai Life Sciences
“Our combined expertise and energy will enable our clients’ molecules to be accelerated through key milestones, while reducing risk and cost.”
– Dr Claire Thompson, CEO & Founder, Agility Life Sciences.
“At its heart, this partnership is about people working side by side to turn promising science into medicines that can change lives.”
– Chris Davison, CEO, Centrix Pharma Solutions